4.7 Article

Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance

期刊

NATURE IMMUNOLOGY
卷 10, 期 6, 页码 636-U109

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1728

关键词

-

资金

  1. Novo Nordisk Foundation
  2. Danish AIDS foundation
  3. Deutsche Forschungsgemeinschaft
  4. Genomes2Vaccines Specific Targeted Research Project
  5. Sixth Framework Programme [LSHB-CT-2003-503231]
  6. Hochschulbauforderungsgesetz Program [HBFG-122-605]
  7. Forschungszentrum Immunologie at the University of Mainz
  8. Nuffield Dominions Trust
  9. Cancer Research UK
  10. European Union [LSHG-CT-2006-031220, LSHC-CT-2006-518234, HEALTH-2007-222773]
  11. Wellcome Trust
  12. James Martin 21st Century School at the University of Oxford
  13. National Institute for Health
  14. UK Medical Research Council
  15. Medical Research Council [MC_U137884177, MC_U137884178, G9900061] Funding Source: researchfish
  16. MRC [G9900061, MC_U137884178, MC_U137884177] Funding Source: UKRI

向作者/读者索取更多资源

Although cytotoxic T lymphocytes (CTLs) in people infected with human immunodeficiency virus type 1 can potentially target multiple virus epitopes, the same few are recognized repeatedly. We show here that CTL immunodominance in regions of the human immunodeficiency virus type 1 group-associated antigen proteins p17 and p24 correlated with epitope abundance, which was strongly influenced by proteasomal digestion profiles, affinity for the transporter protein TAP, and trimming mediated by the endoplasmatic reticulum aminopeptidase ERAAP, and was moderately influenced by HLA affinity. Structural and functional analyses demonstrated that proteasomal cleavage 'preferences' modulated the number and length of epitope-containing peptides, thereby affecting the response avidity and clonality of T cells. Cleavage patterns were affected by both flanking and intraepitope CTL-escape mutations. Our analyses show that antigen processing shapes CTL response hierarchies and that viral evolution modifies cleavage patterns and suggest strategies for in vitro vaccine optimization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据